Dysuria clinical trials
The registry lists 20 studies for Dysuria across more than 10 countries. 3 are recruiting or about to start. 5 of them are mainly about Dysuria (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-29.
Get an email when these change. Save the Dysuria studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Northwell Health (1) · Turku University Hospital (1) · Beni-Suef University (1) · Alta Bates Summit Medical Center (1) · Perfect Care Distribution (1) · Pinnacle Pharmaceuticals, Inc. (1) · Todd Moyerbrailean DO FACOG (1) · Region Skane (1)
What is being tested here
Drugs under test in Dysuria studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tamsulosin | 1 | 0 | 1 |
| Estradiol | 0 | 1 | 1 |
| Methenamine | 0 | 1 | 1 |
| Methylene Blue | 0 | 1 | 1 |
| Lidocaine | 0 | 0 | 1 |
| Water | 0 | 0 | 1 |
| Coconut Oil | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Sep 2027Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. · Northwell Health
Who these studies take
Of the 3 Dysuria studies recruiting now, 1 (33%) set no upper age limit and 1 (33%) stop at 75 or younger. 0 (0%) take children under 18. 2 (67%) are for women only and 1 (33%) for men only; 2 (67%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (33%) | 0 (0%) |
| 30 | 2 (67%) | 0 (0%) |
| 40 | 2 (67%) | 0 (0%) |
| 50 | 1 (33%) | 1 (33%) |
| 65 | 1 (33%) | 1 (33%) |
| 75 | 1 (33%) | 1 (33%) |
| 85 | 1 (33%) | 1 (33%) |
Across all 20 studies, recruiting or not: 35% stop at 75 or younger and 15% at 65; 10% take children; 65% are for women only and 5% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 20 of 20. search them.
- Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.RecruitingNCT05148156Not applicable1 country
- Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in WomenRecruitingNCT05439902Not applicable1 country
- ENDOMET - Novel Diagnostic Tools and Treatments for EndometriosisRecruitingNCT013018851 country
- Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder CancerTerminatedNCT015637961 country
- Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal AtrophyCompletedNCT03332303Phase 31 country
- Intraurethral Lidocaine After Endourology ProceduresTerminatedNCT03537534Phase 31 country
- Percutaneous Posterior Tibial Nerve Stimulation in Post-operative Voiding Dysfunction After Deep Endometriosis SurgeryCompletedNCT04228692Not applicable1 country
- Real-world Evidence Study on the Performance and Safety of Halova OvulesCompletedNCT056546101 country
- Pain Outcomes During Rigid Cystoscopy in Females With and Without Cystoscopic Sheath ObturatorTerminatedNCT05152199Not applicable1 country
- A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic VaginitisCompletedNCT02195986Phase 31 country
- Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary CareCompletedNCT034748871 country
- To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated LaserStatus unknownNCT05156502Not applicable1 country
- Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of DysuriaCompletedNCT01657448Phase 31 country
- Laser Therapy for Vulvovaginal Symptoms in Breast Cancer PatientsStatus unknownNCT03628092Not applicable1 country
- Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?CompletedNCT03210038Not applicable1 country
- GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer SurvivorsTerminatedNCT03185169Early Phase 11 country
- Prevalence of Female Circumcision Among Young Women in Beni-Suef, EgyptCompletedNCT033816121 country
- Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract DysfunctionCompletedNCT02554201Not applicable1 country
- Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract InfectionCompletedNCT01406587Phase 21 country
- Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of DysuriaStatus unknownNCT00969254Phase 3